Search Results

In Memoriam: Ido Weinberg, MD

Friends, colleagues, and the Vascular Medicine community are honoring the life of Dr. Ido Weinberg.

ACT 1 Analysis Shows Low Rate of Stent Fractures and No Association With Major Adverse Events in CAS

September 21, 2016—Ido Weinberg, MD, presented findings on stent fractures in the ACT 1 (Asymptomatic Carotid Trial) study during the third Late-Breaking Trials session at VIVA 16, the 14th annual Vascular InterVentional Advances meeting, which was sponsored by VIVA Physicians, Inc. and held September 18–22, 2016 at the Wynn Las Vegas in Las Vegas, Nevada.  Dr.

Ultrasound Outcomes From ATTRACT Trial Published

August 7, 2019—An evaluation of the relationships of pharmacomechanical catheter-directed thrombolysis (PCDT), sonographic findings, and clinical outcomes in patients with acute proximal deep vein thrombosis (DVT) in the ATTRACT trial were published by Ido Weinberg, MD, et al online in Vascular Medicine.

Analysis of ACT 1 Shows Carotid Stent Fractures Are Not Associated With Adverse Events

January 2, 2018—Findings from a study that sought to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in ACT 1 asymptomatic carotid trial were published by Ido Weinberg, MD, et al in Circulation.

Penumbra’s Indigo Lightning 12 System Evaluated in Real-World STRIKE-PE Study

November 4, 2022—Computer-aided mechanical aspiration thrombectomy with the Indigo Lightning 12 aspiration system (Penumbra, Inc.) for the treatment of pulmonary embolism (PE) was evaluated for real-world safety, performance, and functional outcomes in the STRIKE-PE study.

Interim Analysis Presented From STRIKE-PE Study of Penumbra’s Indigo Aspiration System

November 1, 2023—The STRIKE-PE study is evaluating real-world safety, performance, and long-term quality-of-life outcomes of computer assisted vacuum thrombectomy (CAVT) with the Indigo Aspiration System (Penumbra, Inc.) for the treatment of pulmonary embolism (PE).

Penumbra Launches Lightning Flash Mechanical Thrombectomy System After FDA Clearance

January 10, 2023—Penumbra, Inc. announced the FDA clearance and launch of the company’s Lightning Flash mechanical thrombectomy system.

CRITISCH Registry Compares First-Line Treatments for CLI

December 20, 2016—Results from an interim analysis from the CRITISCH registry of first-line treatments in patients with critical limb ischemia (CLI) suggest that when physicians are free to individualize therapy to CLI patients, the endovascular-first approach achieved a noninferior amputation-free survival (AFS) rate compared to bypass surgery.

CMS Approves Coverage for Supervised Exercise Therapy for PAD Patients

May 30, 2017—The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to cover supervised exercise therapy (SET) for beneficiaries with intermittent claudication for the treatment of symptomatic peripheral artery disease (PAD).

CMS Proposes Coverage of Supervised Exercise Therapy for Symptomatic PAD

March 3, 2017—The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo for supervised exercise therapy (SET) for symptomatic peripheral artery disease (PAD).